ATLANTA, May 17, 2016 (GLOBE NEWSWIRE) — Alimera Sciences (NASDAQ:ALIM), a leader in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that Chief Executive Officer, Dan Myers, will present at the UBS Global Healthcare Conference, to be held May 23 – 25, 2016 at the The Grand Hyatt in New York City, New York. The Company’s presentation will take place Monday, May 23, 2016 at 11:30 AM Eastern Time.
A live broadcast of the conference presentation will be available. To access the broadcast, go to the “Investor Relations” section of the Company’s website at www.alimeraciences.com. A replay of the conference presentation will also be available.
About Alimera Sciences
Alimera Sciences (NASDAQ:ALIM) (Alimera), founded in June 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in our aging populations. Alimera’s commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. For more information, please visit www.alimerasciences.com.
Contact: COCKRELL GROUP 877.889.1972 email@example.com cockrellgroup.com